human plasminogen kringle 人纤溶酶原kringle
human plasminogen activator 人纤溶酶原激活剂
recombinant human plasminogen 重组体人纤溶酶原激活质
human plasminogen kringle 5 人纤溶酶原kringle
human plasminogen activator inhibitor 人pai
K1-3 domain of human plasminogen 人纤溶酶原K
recombinant human plasminogen Kringle 5 重组人源性纤溶酶原Kringle
human plasminogen activator inhibitor 1 人纤溶酶原激活剂抑制物
recombinant human plasminogen Kringle1-3 重组人纤溶酶原Kringle
Urokinase, a human plasminogen activator, is used clinically to promote the dissolution of thrombi.
尿激酶是一种纤溶酶原激活剂，临床上用于治疗血栓。
Objective To investigate effects of two proinflammatory cytokines on the production of plasminogen activator inhibitor 1(PAI 1) by human pleural mesothelial cells(HPMC).
目的研究前炎症细胞因子对人胸膜间皮细胞（HPMC）释放纤溶酶原激活物抑制剂（PAI 1）的诱导效应。
The thrombolytic effect was compared between urokinase (UK) and human tissue plasminogen activator (t-PA) in rabbits with experimental iliofemoral artery thrombus.
本文用尿激酶(UK)和人体组织型纤溶酶原激活剂(t - PA)进行了兔髂股动脉血栓实验性溶解的对照研究。
应用推荐